Next Article in Journal
Multicomponent Approach to the Synthesis of 4-(1H-indol-3-yl)-5-(4-methoxyphenyl)furan-2(5H)-one
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Short Note


Timofey N. Chmovzh
Timofey A. Kudryashev
1 and
Oleg A. Rakitin
N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, 47 Leninsky Prospekt, 119991 Moscow, Russia
Nanotechnology Education and Research Center, South Ural State University, 76 Lenina Avenue, 454080 Chelyabinsk, Russia
Author to whom correspondence should be addressed.
Molbank 2021, 2021(4), M1291;
Submission received: 30 September 2021 / Revised: 21 October 2021 / Accepted: 22 October 2021 / Published: 25 October 2021
(This article belongs to the Special Issue Heteroatom Rich Organic Heterocycles)


Bis(alkylsulfanyl) derivatives of 1,2,5-thiadiazoles fused with aromatic and heteroaromatic rings containing long alkyl chains are of interest as compounds with liquid crystalline properties. In this communication, 4,7-bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 1 was obtained from 4,7-dibromo-[1,2,5]thiadiazolo[3,4-c]pyridine 2 by a combination of two reactions—aromatic nucleophilic substitution SNAr and Buchwald–Hartwig cross-coupling. The structure of the newly synthesized compounds was established by means of elemental analysis; high-resolution mass spectrometry; 1H, 13C NMR, IR and UV spectroscopy; and mass spectrometry.

Graphical Abstract

1. Introduction

Bis(alkylsulfanyl) derivatives of heteroaromatic compounds containing long alkyl chain are of interest as compounds with device applications. In particular, 4,7-bis(dodecylthio)[1,2,5]thiadiazolo[3,4-d]pyridazine possesses liquid crystalline properties [1]; 4,7-bis(alkylthio)benzo[c][1,2,5]thiadiazole has been used as a precursor for discotic liquid crystals for device application in vertical electrode configuration [2]; and octa(alkylthio)substituted zinc phthalocyanines have been used as photosensitizers for photodynamic therapy [3]. The discovery of new 1,2,5-chalcogenadiazoles fused with aromatic and heteroaromatic rings, containing alkylsulfanyl groups with long alkyl chains, is an interesting and important task. 4,7-Bis(alkylthio)[1,2,5]thiadiazolo[3,4-c]pyridines, according to the Reaxys and SciFinder search, have not been described in the literature. Herein, we report the two-step synthesis of 4,7-bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 1 from 4,7-dibromo-[1,2,5]thiadiazolo[3,4-c]pyridine 2.

2. Results and Discussion

Aromatic nucleophilic substitution of 4,7-dibromo[1,2,5]thiadiazolo[3,4-d]pyridazine with thiols led to the formation of 4,7-bis-thiosubstituted [1,2,5]thiadiazolo[3,4-d]pyridazines [4]; all attempts to isolate mono-substituted derivatives were unsuccessful. On the other hand, for the synthesis of 4,7-bis(alkylthio)benzo[c][1,2,5]thiadiazole, Buchwald–Hartwig conditions are required: treatment with alkylthiols and a mixture of Pd2(dba)3, DPPF, and DIPEA [2]. We assumed that the synthesis of 4,7-bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 1 from 4,7-dibromo-[1,2,5]thiadiazolo[3,4-c]pyridine 2 can proceed smoothly through a combination of the two reactions—nucleophilic substitution and Buchwald–Hartwig cross-coupling.
Dibromide 2 was studied in the reaction of aromatic nucleophilic substitution SNAr with dodecane-1-thiol (Scheme 1, Table 1). It was shown that when dibromide 2 was treated with two equivalents of thiol at room temperature in various organic solvents (CHCl3, THF, MeCN, and DMF), only monomercapto derivative 3 was formed (Table 1, entries 1–4). The reaction in an aprotic dipolar solvent (DMF) proceeded much faster than in a less polar organic solvent, chloroform. We showed that the use of sodium thiolate led to an increase in the yield of dodecylthio derivative 3 up to 85% (Table 1, entry 5). Previously, it has been shown that the SNAr reactions with 4,7-dibromo[1,2,5]thiadiazolo[3,4-c]pyridine proceed exclusively at the more electron-deficient position 4, which is closest to the pyridine nitrogen atom [5].
To synthesize the target dithiol 1, we investigated the Buchwald–Hartwig cross-coupling of monothiol 3 with dodecane-1-thiol in the presence of a palladium catalyst tris(dibenzylideneacetone)dipalladium (0) (Pd2(dba)3), a DPPF ligand, and DIPEA as a base. It was found that when the reaction mixture was refluxed in toluene for 6 h, the starting derivative 3 completely disappeared with the formation of 4,7-bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 1 in a high yield. The structures of 7-bromo-4-(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 3 and 4,7-bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 1 were confirmed by means of elemental analysis; high-resolution mass spectrometry; 1H, 13C NMR, IR and UV spectroscopy; and mass spectrometry.
In conclusion, 4,7-bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 1 was successfully prepared from 4,7-dibromo-[1,2,5]thiadiazolo[3,4-c]pyridine 2 by combining two synthetic procedures: aromatic nucleophilic substitution SNAr and Buchwald–Hartwig cross-coupling reaction. The liquid crystalline properties of bis(dodecylthio) derivative are being investigated.

3. Materials and Methods

4,7-Dibromo-[1,2,5]thiadiazolo[3,4-c]pyridine 1 was prepared according to the published method [6]. The solvents and reagents were purchased from commercial sources and used as received. The melting point was determined on a Kofler hot-stage apparatus and was uncorrected. 1H and 13C NMR spectra were taken with a Bruker AM-300 machine (Bruker AXS Handheld Inc., Kennewick, WA, USA) (at frequencies of 300 and 75 MHz) in CDCl3 solution, with TMS as the standard. J values are given in Hz. The MS spectrum (EI, 70 eV) was obtained with a Finnigan MAT INCOS 50 instrument (Hazlet, NJ, USA). The IR spectrum was measured with a Bruker “Alpha-T” instrument (Santa Barbara, CA, USA) in KBr pellet. The high-resolution MS spectrum was measured on a Bruker micrOTOF II instrument (Bruker Daltonik Gmbh, Bremen, Germany) using electrospray ionization (ESI). Solution UV–visible absorption spectra were recorded using an OKB Spektr SF-2000 UV/Vis/NIR spectrophotometer (St. Petersburg, Russia) controlled with SF-2000 software (St. Petersburg, Russia). The sample was measured in a 1 cm quartz cell at room temperature with 4.8 × 10−5 mol/mL concentration in CH2Cl2.
Synthesis of 7-bromo-4-(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 3 (Supplementary Materials).
Sodium hydride (23 mg, 1 mmol) was added to a solution of dodecane-1-thiol (202 mg, 1 mmol) in dry THF (30 mL) at 0 °C with stirring. The reaction mixture was stirred at 0 °C for 30 min, then 4,7-dibromo-[1,2,5]thiadiazolo[3,4-c]pyridine 2 (295 mg, 1 mmol) was added. The mixture was stirred for 3 h at room temperature. On completion (monitored by TLC), the mixture was poured into water (20 mL) and extracted with EtOAc (3 × 35 mL). The combined organic layers were washed with brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel (Silica gel Merck 60, eluent hexane–CH2Cl2, 5:1, v/v). Yield 353 mg (85%), green solid, mp = 54–56 °C;, Rf = 0.2 (CH2Cl2, 5:1, v/v). IR spectrum, ν, cm–1: 2935, 2844, 1466, 1448, 1392, 1353, 1294, 1254, 1222, 1131, 1104, 1006, 906, 854, 695, 524. 1H NMR (ppm): δ 8.48 (1H, s), 3.37 (t, J = 7.3, 2H), 1.81 (p, J = 7.4, 2H), 1.58–1.45 (m, 2H), 1.39–1.23 (m, 16H), 0.89 (t, J = 5.7, 3H). 13C NMR (ppm): δ 157.3, 154.8, 149.3, 145.4, 106.0, 31.9, 29.8, 29.63, 29.62, 29.58, 29.48, 29.34, 29.16, 28.9, 28.8, 22.6, 14.1. HRMS (ESI-TOF), m/z: calcd. for C17H2779BrN3S2 [M + H]+ 416.0824, found, 416.0809. MS (EI, 70eV), m/z (I, %): 419 ([M + 3]+, 9), 418 ([M + 2]+, 37), 417 ([M + 1]+, 30), 416 ([M]+, 38), 415 ([M − 1]+, 27), 247 (70), 41 (100).
Synthesis of 4,7-bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 1 (Supplementary Materials).
7-Bromo-4-(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 2 (300 mg, 0.72 mmol), Pd2(dba)3 (6 mg, 1 mmol%), DPPF (8 mg, 2 mmol%) and DIPEA (0.13 mL, 0.79 mmol) were dissolved in a vial with 10 mL toluene under a stream of nitrogen. After 10 min, dodecane-1-thiol (145 mg, 0.17 mL, 0.72 mmol) was added using a syringe. The temperature of the oil bath was increased to 120 °C, and stirring was continued for 6 h. The reaction mixture was poured into ice-water and extracted by CHCl3 (3 × 10 mL). The combined organic layers were washed with brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel (Silica gel Merck 60, eluent hexane–CH2Cl2, 5:1, v/v). Yield 353 mg (85%), yellow solid, mp = 89–91 °C;, Rf = 0.3 (CH2Cl2, 5:1, v/v). IR spectrum, ν, cm–1: 2956, 2919, 2849, 1540, 1467, 1442, 1299, 1250, 1242,991, 956, 879, 870, 721, 631, 562, 493. 1H NMR (ppm): δ 8.28 (1H, s), 3.37 (t, J = 7.3, 2H), 3.11 (t, J = 7.4, 2H), 1.87–1.77 (m, 2H), 1.72–1.63 (m, 2H), 1.54–1.42 (m, 4H), 1.33–1.23 (m, 32H), 0.89 (t, J = 6.5, 6H). 13C NMR (ppm): δ 156.3, 155.8, 149.3, 144.1, 120.1, 33.2, 2 × 32.0, 29.74, 29.72, 2 × 29.71, 29.70, 29.69, 29.65, 29.60, 29.5, 2 × 29.4, 29.3, 29.28, 29.2, 29.1, 29.0, 28.8, 2 × 22.3, 2 × 14.2. HRMS (ESI-TOF), m/z: calcd. for C29H52N3S3 [M + H]+ 538.3318, found, 538.3308. MS (EI, 70 eV), m/z (I, %): 537 ([M]+, 83), 490 (20), 369 (30), 43 (100). UV–Vis spectra (in CH2Cl2), λmax: 258 nm (ε = 24705 M−1 cm−1), 427 nm (ε = 7294 M−1 cm−1).

Supplementary Materials

The following are available online: copies of 1H, 13C NMR, IR, HRMS and mass spectra for compounds 3 and 1, and UV–Vis and mass spectra for compound 1.

Author Contributions

Conceptualization, O.A.R. and T.N.C.; methodology, O.A.R.; software, T.N.C. and T.A.K.; validation, O.A.R.; formal analysis, T.N.C. and T.A.K.; investigation, T.N.C. and T.A.K.; resources, O.A.R.; data curation, O.A.R.; writing—original draft preparation, O.A.R.; writing—review and editing, O.A.R.; visualization, O.A.R.; supervision, O.A.R.; project administration, O.A.R.; funding acquisition, O.A.R. All authors have read and agreed to the published version of the manuscript.


This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds 13 are available from the authors.


  1. Chmovzh, T.N.; Knyazeva, E.A.; Krukovskaya, N.V.; Rakitin, O.A. Reactions of 4,7-dibromo[1,2,5]thiadiazolo[3,4-d]pyridazine with alcohols. Russ. Chem. Bull. 2020, 69, 2167–2170. [Google Scholar] [CrossRef]
  2. Liu, X.-Y.; Usui, T.; Hanna, J. Self-Directed Orientation of Molecular Columns Based on n-Type Hexaazatrinaphthylenes (HATNAs) for Electron Transport. Chem. Eur. J. 2014, 20, 14207–14212. [Google Scholar] [CrossRef]
  3. Topal, S.Z.; Isci, U.; Kumru, U.; Atilla, D.; Gurek, A.G.; Hirel, C.; Durmus, M.; Tommasino, J.-B.; Luneau, D.; Berber, S.; et al. Use of organic materials in dye-sensitized solar cells. Dalton Trans. 2014, 43, 6897–6908. [Google Scholar] [CrossRef] [PubMed]
  4. Chmovzh, T.N.; Knyazeva, E.A.; Lyssenko, K.A.; Popov, V.V.; Rakitin, O.A. Safe synthesis of 4,7-dibromo[1,2,5]thiadiazolo[3,4-d]pyridazine and its SNAr reactions. Molecules 2018, 23, 2576. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. González-Antonio, O.; Villalobos, M.N.; Vázquez-Alvarado, M.M.; Santillan, R.; Flores-Pérez, B.; Romero-Ávila, M.; Farfán, N. On the nucleophilic derivatization of 4,7-dibromo-[1,2,5]thiadiazolo[3,4-c]pyridine: Basis for biologically interesting species and building blocks for organic materials. New J. Chem. 2019, 43, 10491–10500. [Google Scholar] [CrossRef]
  6. Sun, Y.; Chien, S.-C.; Yip, H.-L.; Zhang, Y.; Chen, K.-S.; Zeigler, D.F.; Chen, F.-C.; Lin, B.; Jen, A.K.-Y. High-mobility low-bandgap conjugated copolymers based on indacenodithiophene and thiadiazolo[3,4-c]pyridine units for thin film transistor and photovoltaic applications. J. Mater. Chem. 2011, 21, 13247–13255. [Google Scholar] [CrossRef]
Scheme 1. Synthesis of 4,7-bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 1.
Scheme 1. Synthesis of 4,7-bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine 1.
Molbank 2021 m1291 sch001
Table 1. Reaction of 4,7-dibromo-[1,2,5]thiadiazolo[3,4-c]pyridine 2 with dodecane-1-thiol.
Table 1. Reaction of 4,7-dibromo-[1,2,5]thiadiazolo[3,4-c]pyridine 2 with dodecane-1-thiol.
EntrySolventBaseTime, hYield, of 3 %
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chmovzh, T.N.; Kudryashev, T.A.; Rakitin, O.A. 4,7-Bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine. Molbank 2021, 2021, M1291.

AMA Style

Chmovzh TN, Kudryashev TA, Rakitin OA. 4,7-Bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine. Molbank. 2021; 2021(4):M1291.

Chicago/Turabian Style

Chmovzh, Timofey N., Timofey A. Kudryashev, and Oleg A. Rakitin. 2021. "4,7-Bis(dodecylthio)-[1,2,5]thiadiazolo[3,4-c]pyridine" Molbank 2021, no. 4: M1291.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop